Identification of potentially hazardous human gene products in GMO risk assessment.
about
Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccinationGeneral considerations on the biosafety of virus-derived vectors used in gene therapy and vaccinationRegeneration of mammalian cochlear and vestibular hair cells through Hes1/Hes5 modulation with siRNAEnvironmental risk assessment of clinical trials involving modified vaccinia virus Ankara (MVA)-based vectors.
P2860
Identification of potentially hazardous human gene products in GMO risk assessment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of potentially hazardous human gene products in GMO risk assessment.
@en
Identification of potentially hazardous human gene products in GMO risk assessment.
@nl
type
label
Identification of potentially hazardous human gene products in GMO risk assessment.
@en
Identification of potentially hazardous human gene products in GMO risk assessment.
@nl
prefLabel
Identification of potentially hazardous human gene products in GMO risk assessment.
@en
Identification of potentially hazardous human gene products in GMO risk assessment.
@nl
P2093
P2860
P356
P1476
Identification of potentially hazardous human gene products in GMO risk assessment.
@en
P2093
Colin Logie
Cécile Van Der Vlugt
Hans Bergmans
Harm Hermsen
Kees Van Maanen
Michelle Meredyth
P2860
P356
10.1051/EBR:2008001
P577
2008-01-01T00:00:00Z